• Recombinant Annexin V Maps Cardiomyocyte Death

  2026-08-22

  The reference study introduced labeled human recombinant Annexin V as an in vivo probe for early phosphatidylserine externalization after myocardial ischemia and reperfusion. By resolving cell-death timing before conventional DNA-fragmentation methods and responding to a cell-death–blocking intervention, the work established a practical framework for testing cardioprotective strategies.

• Candida krusei Phase-Specific Apoptosis in BMECs

  2026-08-22

  The reference study shows that the yeast and hypha phases of Candida krusei trigger bovine mammary epithelial-cell apoptosis through different signaling programs. Its phase-resolved co-culture design links yeast-associated injury mainly to mitochondrial signaling and hypha-associated injury to death ligand/receptor signaling, with TLR- and MAPK-related pathways contributing to both responses.

• Mitochondrial Calcium Signaling Represses Ferroptosis

  2026-08-21

  The reference study identifies a direct mechanistic link between mitochondrial calcium uptake, GPX4 acetylation, and repression of ferroptotic cell death. By combining mouse genetics, cancer-cell models, mutational analysis, and structural interpretation, it shows how MCU-dependent mitochondrial metabolism sustains GPX4 activity and tumor growth.

• GW 4869: Exosome Workflow for Osteogenesis

  2026-08-20

  Use GW 4869 to separate extracellular-vesicle release effects from direct sphingolipid signaling in BMSC and osteogenesis assays. This practical workflow covers donor-cell treatment, Li-Exo comparisons, controls, dosing, and troubleshooting for more defensible exosome biology.

• Lysosomal Exocytosis in MPS IVA Cartilage

  2026-08-20

  A 2026 Disease Models & Mechanisms study identifies enhanced lysosomal exocytosis as a disease-associated feature in galns-mutant zebrafish cartilage. Its central contribution is to connect altered lysosome trafficking with reduced cathepsin activity, disrupted TGFβ/BMP signaling, and abnormal glycosaminoglycan distribution rather than attributing skeletal pathology to storage burden alone.

• Ang II–HIF-1α-HILPDA Axis in NPC Radioresistance

  2026-08-19

  The reference study identifies a local angiotensin II–AGT–HIF-1α–HILPDA circuit that suppresses ferroptosis and promotes radioresistance in nasopharyngeal carcinoma. Its experiments connect lipid-droplet regulation with radiation response and suggest that combining angiotensin II receptor blockade with ferroptosis induction merits further preclinical investigation.

• A-1210477: Mapping MCL-1 Apoptotic Dependency

  2026-08-19

  A-1210477 is an MCL-1 inhibitor for resolving how cancer cells depend on mitochondrial apoptosis. This guide connects binding, BAX/BAK competence, orthogonal assay design, and translational interpretation without overstating in vivo potential.

• Batimastat (BB-94): From MMPs to Synapses

  2026-08-18

  A translational framework for using Batimastat (BB-94) to connect matrix metalloproteinase activity with tumor invasion, angiogenesis, and spatially controlled BDNF processing at developing neuromuscular synapses.

• GLP-1 (9-36) amide for Receptor Studies

  2026-08-18

  GLP-1 (9-36) amide supports controlled blockade experiments that separate GLP-1 receptor activity from ligand cross-reactivity. This guide translates cAMP assay findings into practical workflows for GPCR signaling, metabolic regulation, and type 2 diabetes research.

• LC–MS/MS Maps GS-441524 Prodrug Conversion

  2026-08-17

  A January 2026 Microchemical Journal study established an LC–MS/MS workflow for tracking conversion of the novel GS-441524 prodrug NGP-1 to GS-441524 across gastric fluid, blood, liver microsomes, and a rat liver-injury model. Its findings support a sequential absorption and biotransformation model that can inform oral prodrug design and GS-441524 pharmacokinetics studies.

• BEND Lipids Improve mRNA and CRISPR Delivery

  2026-08-17

  The reference study introduces branched endosomal disruptor lipids as an ionizable-lipid design strategy for improving LNP delivery of mRNA and CRISPR-Cas9 ribonucleoproteins. Its comparative experiments connect terminal lipid branching with enhanced endosomal penetration, hepatic gene-editing performance, and T-cell transfection, while also clarifying the limits of transferring results across cargos and cell types.

• Palonosetron: Evidence for CINV Prevention

  2026-08-16

  The review by Ruhlmann and Herrstedt examines how palonosetron’s high-affinity, allosteric 5-HT3 receptor binding and prolonged half-life may translate into durable control of chemotherapy-induced nausea and vomiting. Its central practical contribution is a balanced comparison of palonosetron with earlier 5-HT3 antagonists, while emphasizing separate assessment of acute emesis, delayed symptoms, nausea, and combination antiemetic therapy.

• Poly-Arginine MIP Sensor for Dimetridazole Detection

  2026-08-15

  The 2020 Analytica Chimica Acta study developed a poly-arginine molecularly imprinted polymer sensor for selective, ultra-trace detection of Dimetridazole (1,2-Dimethyl-5-nitroimidazole). Its GCE/P-Arg@MIP electrode combined electrochemical deposition with differential pulse voltammetry and achieved a 0.1 nM detection limit while supporting analysis in egg, milk, and honey.

• Intravesical p21 mRNA-LNP Therapy in Bladder Cancer

  2026-08-14

  This FASEB Journal study develops chemically modified p21 mRNA encapsulated in lipid nanoparticles for localized intravesical treatment of bladder cancer. The work links tumor-suppressor restoration to cell-cycle inhibition, DNA-damage signaling, apoptosis, bladder-localized expression, and tumor suppression in an orthotopic mouse model.

• Fluoxetine HCl: Serotonergic Mechanisms & Research

  2026-08-14

  Fluoxetine HCl is a selective serotonin reuptake inhibitor used to examine serotonin transporter activity, 5-HT2C receptor signaling, neurogenesis, and behavior. Its research value depends on separating acute receptor assays from chronic plasticity models and developmental exposure paradigms.

8077 records 1/539 page Next 12345 下5页 Last page